Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 18 studies | 40% ± 19% | |
endothelial cell | 8 studies | 33% ± 18% | |
plasma cell | 7 studies | 26% ± 12% | |
B cell | 7 studies | 25% ± 6% | |
macrophage | 6 studies | 24% ± 5% | |
epithelial cell | 6 studies | 24% ± 7% | |
basal cell | 6 studies | 27% ± 7% | |
retinal rod cell | 5 studies | 27% ± 7% | |
memory B cell | 5 studies | 22% ± 5% | |
naive B cell | 5 studies | 20% ± 4% | |
pericyte | 4 studies | 30% ± 13% | |
type I pneumocyte | 4 studies | 25% ± 8% | |
retinal cone cell | 4 studies | 30% ± 11% | |
CD4-positive, alpha-beta T cell | 4 studies | 21% ± 2% | |
conventional dendritic cell | 4 studies | 22% ± 2% | |
mast cell | 4 studies | 19% ± 2% | |
deuterosomal cell | 3 studies | 25% ± 1% | |
capillary endothelial cell | 3 studies | 24% ± 3% | |
Mueller cell | 3 studies | 41% ± 8% | |
enteroendocrine cell | 3 studies | 16% ± 1% | |
goblet cell | 3 studies | 19% ± 2% | |
gamma-delta T cell | 3 studies | 21% ± 5% | |
CD8-positive, alpha-beta T cell | 3 studies | 22% ± 3% | |
natural killer cell | 3 studies | 25% ± 7% | |
regulatory T cell | 3 studies | 19% ± 3% | |
mature NK T cell | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 430.43 | 245 / 245 | 100% | 23.63 | 502 / 502 |
brain | 98% | 354.28 | 2599 / 2642 | 97% | 5.76 | 685 / 705 |
kidney | 99% | 344.00 | 88 / 89 | 95% | 9.27 | 859 / 901 |
bladder | 100% | 321.71 | 21 / 21 | 90% | 6.38 | 454 / 504 |
pancreas | 94% | 197.24 | 309 / 328 | 96% | 7.03 | 170 / 178 |
uterus | 94% | 285.97 | 160 / 170 | 95% | 9.27 | 435 / 459 |
ovary | 100% | 808.34 | 180 / 180 | 89% | 4.58 | 382 / 430 |
skin | 93% | 336.37 | 1690 / 1809 | 95% | 8.09 | 448 / 472 |
breast | 99% | 357.97 | 456 / 459 | 89% | 4.38 | 990 / 1118 |
thymus | 97% | 282.28 | 633 / 653 | 90% | 4.96 | 546 / 605 |
lung | 96% | 311.10 | 552 / 578 | 88% | 5.90 | 1020 / 1155 |
esophagus | 98% | 568.04 | 1422 / 1445 | 80% | 3.90 | 147 / 183 |
intestine | 94% | 265.41 | 912 / 966 | 83% | 5.46 | 437 / 527 |
adrenal gland | 63% | 149.68 | 163 / 258 | 93% | 7.72 | 213 / 230 |
stomach | 86% | 208.43 | 307 / 359 | 69% | 3.63 | 198 / 286 |
liver | 75% | 270.31 | 169 / 226 | 54% | 3.21 | 218 / 406 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.45 | 1 / 1 |
blood vessel | 100% | 1395.51 | 1333 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 441.42 | 1192 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 432.97 | 794 / 803 | 0% | 0 | 0 / 0 |
spleen | 98% | 241.94 | 236 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 9.70 | 44 / 45 |
lymph node | 0% | 0 | 0 / 0 | 97% | 6.39 | 28 / 29 |
heart | 95% | 411.26 | 818 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 79% | 3.19 | 63 / 80 |
peripheral blood | 62% | 569.84 | 574 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0001673 | Cellular component | male germ cell nucleus |
GO_0005737 | Cellular component | cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0005515 | Molecular function | protein binding |
Gene name | ANKRD37 |
Protein name | Ankyrin repeat domain-containing protein 37 (Low-density lipoprotein receptor-related protein 2-binding protein) (hLrp2bp) Ankyrin repeat domain 37 |
Synonyms | LPR2BP |
Description | |
Accessions | ENST00000507753.1 ENST00000335174.6 D6RFF5 Q7Z713 |